Splenic vein thrombosis medical therapy

Splenic vein thrombosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Splenic vein thrombosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Guidelines for Management
Case Studies
Case #1
Splenic vein thrombosis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Splenic vein thrombosis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Splenic vein thrombosis medical therapy
CDC on Splenic vein thrombosis medical therapy
Splenic vein thrombosis medical therapy in the news
Blogs on Splenic vein thrombosis medical therapy
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Splenic vein thrombosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

Medical therapy for splenic vein thrombosis include anti coagulation to maintain INR between 2 to 3. The goal of anticoagulation is to prevent extension of the clot and to allow for recanalization so that intestinal infarction and portal hypertension do not develop.

• The mainstay of therapy in splenic vein thrombosis with gastric varices is sclerotherapy and gastric banding

Medical therapy

Medical therapy for splenic vein thrombosis include anti coagulation to maintain INR between 2 to 3. The goal of anticoagulation is to prevent extension of the clot and to allow for recanalization so that intestinal infarction and portal hypertension do not develop. The mainstay of therapy in splenic vein thrombosis with gastric varices is sclerotherapy and gastric banding

• Correction of the causal factors
  • Prevention of thrombosis extension
  • Achievement of splenic vein patency
  • Management of complications related to pancreatitis

• NOTE (1):Initiate anticougulation with heparin for 3-4 weeks then start oral vitamin K antagonist(e.g. warfarin) to maintain INR between 2 to 3.

• • Improves re canalization rates

• • Decrease development of gastric varices and complications associated with varices